Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1988 Apr;43(4):306–311. doi: 10.1136/thx.43.4.306

Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.

M K Albazzaz 1, K R Patel 1
PMCID: PMC461218  PMID: 2900560

Abstract

Azelastine, a new oral agent with antiallergic and antihistamine properties, has been shown to inhibit the effect of histamine and leukotriene (LT) in vitro, though not a specific leukotriene receptor antagonist. The effect of both a single dose (8.8 mg) and 14 days' treatment (8.8 mg twice daily) with azelastine on bronchoconstriction induced by LTC4 and histamine has been examined in 10 patients with mild asthma in a placebo controlled, double blind, crossover study. LTC4 and histamine were inhaled in doubling concentrations from a dosimeter and the results expressed as the cumulative dose (PD) producing a 20% fall in FEV1 (PD20FEV1) and 35% fall in specific airways conductance (PD35sGaw). The single dose of azelastine produced a significantly greater FEV1 and sGaw values than placebo at 3 hours, but this bronchodilator effect was not present after 14 days of treatment. Azelastine was an effective H1 antagonist; after a single dose and 14 days' treatment with placebo the geometric mean PD20FEV1 histamine values (mumol) were 0.52 (95% confidence interval 0.14-1.83) and 0.54 (0.12-2.38), compared with 22.9 (11.5-38.3) and 15.2 (6.47-35.6) after azelastine (p less than 0.01 for both). LTC4 was on average 1000 times more potent than histamine in inducing bronchoconstriction. Azelastine did not inhibit the effect of inhaled LTC4; the geometric mean PD20FEV1 LTC4 (nmol) after a single dose and 14 days' treatment was 0.60 and 0.59 with placebo compared with 0.65 and 0.75 with azelastine. The PD35sGaw LTC4 was also unchanged at 0.66 and 0.73 for placebo compared with 0.83 and 0.74 for azelastine. Thus prolonged blockade of H1 receptors did not attenuate the response to LTC4, suggesting that histamine and LTC4 act on bronchial smooth muscle through different receptors. Four patients complained of drowsiness while taking azelastine but only one who was taking placebo and three patients complained of a bitter, metallic taste while taking azelastine.

Full text

PDF
306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Cerrina J., Duroux P., Floch A., Pradel J., Renier A. Sodium cromoglycate, verapamil and nicardipine antagonism to leukotriene D4 bronchoconstriction. Br J Pharmacol. 1983 Feb;78(2):301–306. doi: 10.1111/j.1476-5381.1983.tb09395.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes N. C., Piper P. J., Costello J. F. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax. 1984 Jul;39(7):500–504. doi: 10.1136/thx.39.7.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnes N., Piper P. J., Costello J. The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man. J Allergy Clin Immunol. 1987 May;79(5):816–821. doi: 10.1016/0091-6749(87)90215-6. [DOI] [PubMed] [Google Scholar]
  4. Burke J. A., Levi R., Guo Z. G., Corey E. J. Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. J Pharmacol Exp Ther. 1982 Apr;221(1):235–241. [PubMed] [Google Scholar]
  5. Chand N., Pillar J., Diamantis W., Perhach J. L., Jr, Sofia R. D. Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action. Eur J Pharmacol. 1983 Dec 23;96(3-4):227–233. doi: 10.1016/0014-2999(83)90311-4. [DOI] [PubMed] [Google Scholar]
  6. Church M. K., Gradidge C. F. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol. 1980 Aug;69(4):663–667. doi: 10.1111/j.1476-5381.1980.tb07919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clee M. D., Ingram C. G., Reid P. C., Robertson A. S. The effect of astemizole on exercise-induced asthma. Br J Dis Chest. 1984 Apr;78(2):180–183. [PubMed] [Google Scholar]
  8. Creese B. R., Bach M. K. Hyperreactivity of airways smooth muscle produced in vitro by leukotrienes. Prostaglandins Leukot Med. 1983 Jun;11(2):161–169. doi: 10.1016/0262-1746(83)90016-1. [DOI] [PubMed] [Google Scholar]
  9. Creticos P. S., Peters S. P., Adkinson N. F., Jr, Naclerio R. M., Hayes E. C., Norman P. S., Lichtenstein L. M. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21;310(25):1626–1630. doi: 10.1056/NEJM198406213102502. [DOI] [PubMed] [Google Scholar]
  10. Dahlén S. E., Hansson G., Hedqvist P., Björck T., Granström E., Dahlén B. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Proc Natl Acad Sci U S A. 1983 Mar;80(6):1712–1716. doi: 10.1073/pnas.80.6.1712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dahlén S. E., Hedqvist P., Hammarström S., Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature. 1980 Dec 4;288(5790):484–486. doi: 10.1038/288484a0. [DOI] [PubMed] [Google Scholar]
  12. Dorward A. J., Patel K. R. Inhaled ketotifen in exercise-induced asthma--a negative report. Eur J Respir Dis. 1985 Nov;67(5):378–380. [PubMed] [Google Scholar]
  13. Drazen J. M., Austen K. F. Atropine modification of the pulmonary effects of chemical mediators in the guinea pig. J Appl Physiol. 1975 May;38(5):834–838. doi: 10.1152/jappl.1975.38.5.834. [DOI] [PubMed] [Google Scholar]
  14. Drazen J. M., Austen K. F., Lewis R. A., Clark D. A., Goto G., Marfat A., Corey E. J. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4354–4358. doi: 10.1073/pnas.77.7.4354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Griffin M., Weiss J. W., Leitch A. G., McFadden E. R., Jr, Corey E. J., Austen K. F., Drazen J. M. Effects of leukotriene D on the airways in asthma. N Engl J Med. 1983 Feb 24;308(8):436–439. doi: 10.1056/NEJM198302243080807. [DOI] [PubMed] [Google Scholar]
  16. Holgate S. T., Emanuel M. B., Howarth P. H. Astemizole and other H1-antihistaminic drug treatment of asthma. J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):375–380. doi: 10.1016/0091-6749(85)90657-8. [DOI] [PubMed] [Google Scholar]
  17. Katayama S., Akimoto N., Shionoya H., Morimoto T., Katoh Y. Anti-allergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro. Arzneimittelforschung. 1981;31(8):1196–1203. [PubMed] [Google Scholar]
  18. Kuehl F. A., Jr, DeHaven R. N., Pong S. S. Lung tissue receptors for sulfidopeptide leukotrienes. J Allergy Clin Immunol. 1984 Sep;74(3 Pt 2):378–381. doi: 10.1016/0091-6749(84)90134-9. [DOI] [PubMed] [Google Scholar]
  19. Lee T. H., Austen K. F., Corey E. J., Drazen J. M. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4922–4925. doi: 10.1073/pnas.81.15.4922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lee T. H., Austen K. F., Corey E. J., Drazen J. M. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4922–4925. doi: 10.1073/pnas.81.15.4922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lewis R. A., Austen K. F. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest. 1984 Apr;73(4):889–897. doi: 10.1172/JCI111312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nathan R. A., Segall N., Schocket A. L. A comparison of the actions of H1 and H2 antihistamines on histamine-induced bronchoconstriction and cutaneous wheal response in asthmatic patients. J Allergy Clin Immunol. 1981 Mar;67(3):171–177. doi: 10.1016/0091-6749(81)90057-9. [DOI] [PubMed] [Google Scholar]
  23. Nogrady S. G., Bevan C. Inhaled antihistamines--bronchodilatation and effects on histamine- and methacholine-induced bronchoconstriction. Thorax. 1978 Dec;33(6):700–704. doi: 10.1136/thx.33.6.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ollier S., Gould C. A., Davies R. J. The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing. J Allergy Clin Immunol. 1986 Aug;78(2):358–364. doi: 10.1016/s0091-6749(86)80090-2. [DOI] [PubMed] [Google Scholar]
  25. Patel K. R. Terfenadine in exercise induced asthma. Br Med J (Clin Res Ed) 1984 May 19;288(6429):1496–1497. doi: 10.1136/bmj.288.6429.1496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pong S. S., DeHaven R. N. Characterization of a leukotriene D4 receptor in guinea pig lung. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7415–7419. doi: 10.1073/pnas.80.24.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Popa V. T. Bronchodilating activity of an H1 blocker, chlorpheniramine. J Allergy Clin Immunol. 1977 Jan;59(1):54–63. doi: 10.1016/0091-6749(77)90177-4. [DOI] [PubMed] [Google Scholar]
  28. Roberts J. A., Pugh J. R., Thomson N. C. A new adaptable computerized system for the measurement of specific airways conductance. Br J Dis Chest. 1986 Jul;80(3):218–228. doi: 10.1016/0007-0971(86)90056-2. [DOI] [PubMed] [Google Scholar]
  29. Smith L. J., Greenberger P. A., Patterson R., Krell R. D., Bernstein P. R. The effect of inhaled leukotriene D4 in humans. Am Rev Respir Dis. 1985 Mar;131(3):368–372. doi: 10.1164/arrd.1985.131.3.368. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES